{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T14:00:39Z","timestamp":1787752839410,"version":"build-2784847793"},"reference-count":88,"publisher":"American Society for Microbiology","issue":"3","license":[{"start":{"date-parts":[[2024,3,5]],"date-time":"2024-03-05T00:00:00Z","timestamp":1709596800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2024,3,5]],"date-time":"2024-03-05T00:00:00Z","timestamp":1709596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"DOI":"10.13039\/100000062","name":"HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"crossref","award":["1R01DK131267-01"],"award-info":[{"award-number":["1R01DK131267-01"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Microbiol Spectr"],"published-print":{"date-parts":[[2024,3,5]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:sec>\n            <jats:title\/>\n            <jats:p>\n              Management of urinary tract infection (UTI) in postmenopausal women can be challenging. The recent rise in resistance to most of the available oral antibiotic options together with high recurrence rate in postmenopausal women has further complicated treatment of UTI. As such, intravesical instillations of antibiotics like gentamicin are being investigated as an alternative to oral antibiotic therapies. This study evaluates the efficacy of the candidate intravesical therapeutic VesiX, a solution containing the cationic detergent Cetylpyridinium chloride, against a broad range of uropathogenic bacterial species clinically isolated from postmenopausal women with recurrent UTI (rUTI). We also evaluate the cytotoxicity of VesiX against cultured bladder epithelial cells and find that low concentrations of 0.0063% and 0.0125% provide significant bactericidal effect toward diverse bacterial species including uropathogenic\n              <jats:italic>Escherichia coli<\/jats:italic>\n              (UPEC),\n              <jats:italic>Klebsiella pneumoniae<\/jats:italic>\n              ,\n              <jats:italic>Enterococcus faecalis<\/jats:italic>\n              ,\n              <jats:italic>Pseudomonas aeruginosa<\/jats:italic>\n              , and\n              <jats:italic>Proteus mirabilis<\/jats:italic>\n              while minimizing cytotoxic effects against cultured 5637 bladder epithelial cells. Lastly, to begin to evaluate the potential utility of using VesiX in combination therapy with existing intravesical therapies for rUTI, we investigate the combined effects of VesiX and the intravesical antibiotic gentamicin. We find that VesiX and gentamicin are not antagonistic and are able to reduce levels of intracellular UPEC in cultured bladder epithelial cells.\n            <\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>IMPORTANCE<\/jats:title>\n            <jats:p>When urinary tract infections (UTIs), which affect over 50% of women, become resistant to available antibiotic therapies dangerous complications like kidney infection and lethal sepsis can occur. New therapeutic paradigms are needed to expand our arsenal against these difficult to manage infections. Our study investigates VesiX, a Cetylpyridinium chloride (CPC)-based therapeutic, as a candidate broad-spectrum antimicrobial agent for use in bladder instillation therapy for antibiotic-resistant UTI. CPC is a cationic surfactant that is FDA-approved for use in mouthwashes and is used as a food additive but has not been extensively evaluated as a UTI therapeutic. Our study is the first to investigate its rapid bactericidal kinetics against diverse uropathogenic bacterial species isolated from postmenopausal women with recurrent UTI and host cytotoxicity. We also report that together with the FDA-approved bladder-instillation agent gentamicin, VesiX was able to significantly reduce intracellular populations of uropathogenic bacteria in cultured bladder epithelial cells.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1128\/spectrum.02712-23","type":"journal-article","created":{"date-parts":[[2024,1,19]],"date-time":"2024-01-19T13:59:10Z","timestamp":1705672750000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":5,"title":["VesiX cetylpyridinium chloride is rapidly bactericidal and reduces uropathogenic\n            <i>Escherichia coli<\/i>\n            bladder epithelial cell invasion\n            <i>in vitro<\/i>"],"prefix":"10.1128","volume":"12","author":[{"given":"Namrata V.","family":"Sawant","sequence":"first","affiliation":[{"name":"Department of Biological Sciences, The University of Texas at Dallas, Richardson, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel S.","family":"Chang","sequence":"additional","affiliation":[{"name":"Department of Biological Sciences, The University of Texas at Dallas, Richardson, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krutika A.","family":"Pandit","sequence":"additional","affiliation":[{"name":"Department of Biological Sciences, The University of Texas at Dallas, Richardson, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prachi","family":"Khekare","sequence":"additional","affiliation":[{"name":"Department of Biological Sciences, The University of Texas at Dallas, Richardson, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Randolph","family":"Warner","sequence":"additional","affiliation":[{"name":"US BioPharma LLC, Punta Gorda, Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7612-2042","authenticated-orcid":true,"given":"Philippe E.","family":"Zimmern","sequence":"additional","affiliation":[{"name":"Department of Urology, The University of Texas Southwestern Medical Center, Dallas, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7670-5301","authenticated-orcid":true,"given":"Nicole J.","family":"De Nisco","sequence":"additional","affiliation":[{"name":"Department of Biological Sciences, The University of Texas at Dallas, Richardson, Texas, USA"},{"name":"Department of Urology, The University of Texas Southwestern Medical Center, Dallas, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro3432"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1097\/SPV.0000000000000509"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000000296"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/MMBR.00067-15"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12937-022-00769-x"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/tog.12644"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2017.08.070"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199911253412211"},{"key":"e_1_3_4_10_2","unstructured":"Anonymous. 2022 Global antimicrobial resistance and use surveillance system (GLASS) report 2022. License: CC BY-NC-SA 3.0 IGO. Geneva: World Health Organisation."},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.97.16.8829"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit284"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0083637"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00090-08"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1574-6968.2008.01218.x"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1601720113"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0602136103"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dki002"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.70.12.7042-7049.2002"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1574-6976.2012.00339.x"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00014-10"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00192-021-05042-z"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.21037\/tau.2017.04.08"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)70072-9"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1960.tb07016.x"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410x.1979.tb03594.x"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.3109\/inf.1978.10.issue-1.16"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410x.1975.tb06257.x"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-5347(17)43237-x"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1D623"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.1996.tb03760.x"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-013-0507-y"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpurol.2020.08.007"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)00928-6"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2018.10.004"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/0090-4295(94)90249-6"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.5489\/cuaj.4945"},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.5489\/cuaj.4434"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.42.6.1476"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.20411\/pai.v2i2.200"},{"key":"e_1_3_4_41_2","doi-asserted-by":"publisher","DOI":"10.1002\/jps.3030340103"},{"key":"e_1_3_4_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2022.115913"},{"key":"e_1_3_4_43_2","article-title":"Therapeutic mouthrinses: reaching beyond mechanical plaque control for reduction in dental plaque and gingivitis","volume":"6","author":"Alexander D","year":"2011","unstructured":"Alexander D. 2011. Therapeutic mouthrinses: reaching beyond mechanical plaque control for reduction in dental plaque and gingivitis. Inside Dentistry 6","journal-title":"Inside Dentistry"},{"key":"e_1_3_4_44_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-051X.2007.01103.x"},{"key":"e_1_3_4_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2011.07.016"},{"key":"e_1_3_4_46_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1601-5037.2008.00344.x"},{"key":"e_1_3_4_47_2","first-page":"401","article-title":"Pharmacological and toxicological studies on cetylpyridinium chloride, a new germicide","volume":"74","author":"Warren MR","year":"1942","unstructured":"Warren MR, Becker TJ, Marsh DG, Shelton RS. 1942. Pharmacological and toxicological studies on cetylpyridinium chloride, a new germicide. J Pharmacol Exp Ther 74:401.","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_3_4_48_2","first-page":"204","article-title":"A comparative investigation to evaluate the clinical efficacy of an alcohol-free CPC-containing mouthwash as compared to a control mouthwash in controlling dental plaque and gingivitis","volume":"22","author":"Ayad F","year":"2011","unstructured":"Ayad F, Prado R, Mateo LR, Stewart B, Szewczyk G, Arvanitidou E, Panagakos FS. 2011. A comparative investigation to evaluate the clinical efficacy of an alcohol-free CPC-containing mouthwash as compared to a control mouthwash in controlling dental plaque and gingivitis. J Clin Dent 22:204\u2013212.","journal-title":"J Clin Dent"},{"key":"e_1_3_4_49_2","first-page":"42","article-title":"Cetylpyridinium chloride mouth rinse on gingivitis and plaque","volume":"82","author":"Asadoorian J","year":"2008","unstructured":"Asadoorian J, Williams KB. 2008. Cetylpyridinium chloride mouth rinse on gingivitis and plaque. American Dental Hygienists Association 82:42.","journal-title":"American Dental Hygienists Association"},{"key":"e_1_3_4_50_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-18367-6"},{"key":"e_1_3_4_51_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00576-20"},{"key":"e_1_3_4_52_2","doi-asserted-by":"publisher","DOI":"10.1128\/jb.52.1.111-117.1946"},{"key":"e_1_3_4_53_2","article-title":"The germicidal action of cetyl pyridinium chloride on bacterial spores","volume":"41","author":"Green T","year":"1941","unstructured":"Green T, Birkeland J. 1941. The germicidal action of cetyl pyridinium chloride on bacterial spores. J Bacteriol 41","journal-title":"J Bacteriol"},{"key":"e_1_3_4_54_2","doi-asserted-by":"publisher","DOI":"10.1002\/mbo3.695"},{"key":"e_1_3_4_55_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-302X.2007.00409.x"},{"key":"e_1_3_4_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.oooo.2012.12.014"},{"key":"e_1_3_4_57_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0207262"},{"key":"e_1_3_4_58_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2020.104818"},{"key":"e_1_3_4_59_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2019.01.004"},{"key":"e_1_3_4_60_2","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms9030521"},{"key":"e_1_3_4_61_2","doi-asserted-by":"publisher","DOI":"10.1177\/10600280221112111"},{"key":"e_1_3_4_62_2","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2007.521"},{"key":"e_1_3_4_63_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.69.7.4572-4579.2001"},{"key":"e_1_3_4_64_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2019.04.008"},{"key":"e_1_3_4_65_2","doi-asserted-by":"publisher","DOI":"10.1101\/2023.05.18.541374"},{"key":"e_1_3_4_66_2","doi-asserted-by":"publisher","DOI":"10.3791\/62872"},{"key":"e_1_3_4_67_2","doi-asserted-by":"publisher","DOI":"10.1128\/JB.01981-07"},{"key":"e_1_3_4_68_2","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.803409"},{"key":"e_1_3_4_69_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkab421"},{"key":"e_1_3_4_70_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.101023"},{"key":"e_1_3_4_71_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00192-020-04303-7"},{"key":"e_1_3_4_72_2","doi-asserted-by":"publisher","DOI":"10.1242\/bio.20121115"},{"key":"e_1_3_4_73_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-021-05830-4"},{"key":"e_1_3_4_74_2","doi-asserted-by":"publisher","DOI":"10.4021\/jocmr1535w"},{"key":"e_1_3_4_75_2","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2015.0292"},{"key":"e_1_3_4_76_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0966-842x(00)01913-2"},{"key":"e_1_3_4_77_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.579389"},{"key":"e_1_3_4_78_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2017.01.003"},{"key":"e_1_3_4_79_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2021.102701"},{"key":"e_1_3_4_80_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1996.tb00834.x"},{"key":"e_1_3_4_81_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.274.5293.1672"},{"key":"e_1_3_4_82_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.286.5443.1358"},{"key":"e_1_3_4_83_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0031-1296752"},{"key":"e_1_3_4_84_2","volume-title":"CLSI Supplmenet M100","author":"CLSI","year":"2020","unstructured":"CLSI. 2020. Performance standards for antimicrobial susceptibility testing. CLSI Supplmenet M100. Clinical and Laboratory Standards Institute, Wayne, PA."},{"key":"e_1_3_4_85_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1469-0691.2003.00790.x"},{"key":"e_1_3_4_86_2","doi-asserted-by":"publisher","DOI":"10.1086\/381972"},{"key":"e_1_3_4_87_2","doi-asserted-by":"publisher","DOI":"10.1089\/mdr.2015.0251"},{"key":"e_1_3_4_88_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00497-10"},{"key":"e_1_3_4_89_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.0030100"}],"container-title":["Microbiology Spectrum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/spectrum.02712-23","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/spectrum.02712-23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,5]],"date-time":"2024-03-05T14:02:10Z","timestamp":1709647330000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/spectrum.02712-23"}},"subtitle":[],"editor":[{"given":"Bonnie Chase","family":"Prokesch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2024,3,5]]},"references-count":88,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3,5]]}},"alternative-id":["10.1128\/spectrum.02712-23"],"URL":"https:\/\/doi.org\/10.1128\/spectrum.02712-23","relation":{},"ISSN":["2165-0497"],"issn-type":[{"value":"2165-0497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,5]]},"assertion":[{"value":"2023-06-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-12-11","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-01-19","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e02712-23"}}